Manish Mital
@Braidwell Lp
Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
4013⤦Guardant Health Inc
| 6.13% | $215.984M 268.252M shares@ $0.81 avg price | |
1080⤦Bridgebio Pharma Inc
| 4.13% | $145.613M 140.838M shares@ $1.04 avg price | |
6701⤦Novocure Ltd
| 3.78% | $133.257M 140.834M shares@ $0.95 avg price | |
CGONCg Oncology Inc
| 3.4% | $119.637M 3.171M shares@ $37.74 avg price | Decreased -4.18% |
6707⤦Nuvasive Inc
| 3.18% | $111.855M 114.206M shares@ $0.98 avg price | |
XENEXenon Pharmaceuticals Inc
| 3.03% | $106.585M 2.707M shares@ $39.37 avg price | Increased 5.73% |
NBIXNeurocrine Biosciences Inc
| 3% | $105.734M 917,674 shares@ $115.22 avg price | Increased 20.91% |
6404⤦Neogenomics Inc
| 2.75% | $96.887M 116.381M shares@ $0.84 avg price | |
APGEApogee Therapeutics Inc
| 2.74% | $96.523M 1.643M shares@ $58.74 avg price | Decreased -31.3% |
APLSApellis Pharmaceuticals Inc
| 2.56% | $90.13M 3.125M shares@ $28.85 avg price | Increased 410.82% |